NRX Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • NRX Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 127 %, a 98.3% decline year-over-year.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2023 was 573 %.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2022 was -196 %, a 102% decline from 2021.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2021 was 9.11K %, a 2478% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 573 +769 Jan 1, 2023 Dec 31, 2023
2022 -196 -9.3K -102% Jan 1, 2022 Dec 31, 2022
2021 9.11K +8.75K +2478% Jan 1, 2021 Dec 31, 2021
2020 353 +337 +2096% Jan 1, 2020 Dec 31, 2020
2019 16.1 +14.8 +1116% Jan 1, 2019 Dec 31, 2019
2018 1.32 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.